US$ 27.56
alternative glp-1 medication A new FDA-approved obesity pill could offer a lower-cost to injectable drugs like Ozempic and Mounjaro. In a major clinical trial, people taking the highest dose lost about 11% of GLP-TRIM - A Natural GLP-1
Description
Of note, in the cost effectiveness study by Lim et al

Obesity is a risk factor for poor overall health, reduced functional capacity, decreased quality of life and is associated with a myriad of chronic conditions

[DOI] [PubMed] [Google Scholar] 17.Scott M.B., Styring A.K., McCullagh J.S.O

Mol Hum Reprod (2017) 23(10):698707

Zhou B, Dong C, Zhao B, Su X, Luo Y, Xie L, et al

doi: 10.1523/jneurosci.0529-11.2011
